Results 131 to 140 of about 111,477 (307)
Cytokine Couture: Designer IL2 Molecules for the Treatment of Disease
Amy Dashwood,1,2 Arman Ali Ghodsinia,1 James Dooley,1 Adrian Liston1 1Department of Pathology, University of Cambridge, Cambridge, UK; 2Immunology Programme, Babraham Institute, Cambridge, UKCorrespondence: Amy Dashwood; Email ajd241@cam.ac.uk Adrian ...
Dashwood A +3 more
doaj
Helios expression in Tregs in different ages.
Helios expression in Tregs in different ages.
Ulf H. Beier (188290) +4 more
core +1 more source
Enhancing CAR‐T Cell Efficacy in Solid Tumors by Inhibiting CCL5/VEGF‐Mediated Angiogenesis
This study reveals that CAR‐T cells in solid tumors produce CCL5, which paradoxically induces VEGF and angiogenesis to promote tumor growth. Blocking CCL5/VEGF signaling—through gene knockout, or the CCR5 inhibitor maraviroc—significantly enhances the antitumor efficacy of CAR‑T therapy (the diagram was created in Biorender).
Shishuo Sun +15 more
wiley +1 more source
Suppressive and immunoprotective functions of Tregs
CD4+CD25+Foxp3+ T lymphocytes, known as regulatory T cells or Tregs, have been proposed to be a lineage of professional immune suppressive cells that exclusively counteract the effects of the immunoprotective "helper" and "cytotoxic" ...
Lixin Zheng +5 more
core +1 more source
Prostate cancer is immunologically ‘cold’, with scarce, dysfunctional type 1 conventional dendritic cells (cDC1s) that limit T cell priming. We introduce an aptamer‐targeted liposomedelivering FMS‐like tyrosine kinase 3 ligand (Flt3L) and chlorin e6 (Ce6). Ultrasound induces antigen release and cDC1s recruitment, creating an in situ cDC1 vaccine.
Jiayi Wang +8 more
wiley +1 more source
Third party approach using cord blood Tregs in allo-transplantation [PDF]
Compelling data has demonstrated the fundamental role of regulatory T cells (Tregs) in immuno-regulation. In vivo animal models indicate that recipient’s CD4pos CD25pos T cells adoptively transferred can prevent or control graft versus host disease ...
Figueroa Tentori, D.
core
Targeting tumor-infiltrating tregs for improved antitumor responses [PDF]
Immunotherapies have revolutionized the landscape of cancer treatment. Regulatory T cells (Tregs), as crucial components of the tumor immune environment, has great therapeutic potential.
Xiaoyu Li +5 more
core +1 more source
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source
Zhengjiang Wang,1,2,* Jiaqi Xu,1,2,* Liqun Mo,1 Renshu Zhan,1,2 Jin Zhang,3 Li Liu,1,2 Jun Jiang,4 Yingying Zhang,1,2 Yiping Bai1,2 1Department of Anesthesiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province ...
Jiang J +8 more
core
Intragraft memory-like CD127hiCD4+Foxp3+ Tregs maintain transplant tolerance
CD4+Foxp3+ regulatory T cells (Tregs) play an essential role in suppressing transplant rejection, but their role within the graft and heterogeneity in tolerance are poorly understood.
Brian S. Gloss +18 more
core +1 more source

